PHP
VERA icon

Parkman Healthcare Partners’s Vera Therapeutics VERA Stock Holding History

Parkman Healthcare Partners’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-100,564
Closed -$5.09M – 116
2025
Q4 		$5.09M Buy
100,564
+3,827
+4% +$136K 0.48% 63
2025
Q3 		$2.81M Sell
96,737
-19,606
-17% -$453K 0.29% 76
2025
Q2 		$2.74M Buy
116,343
+40,218
+53% +$904K 0.32% 74
2025
Q1 		$1.83M Buy
+76,125
New +$2.45M 0.22% 77
2022
Q1 		– Sell
-21,555
Closed -$576K – 94
2021
Q4 		$576K Sell
21,555
-4,083
-16% -$90.3K 0.13% 83
2021
Q3 		$445K Sell
25,638
-50,000
-66% -$894K 0.11% 73
2021
Q2 		$1M Buy
+75,638
New +$1.18M 0.22% 73

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Parkman Healthcare Partners's VERA Position: Q1 2026 in Review

Parkman Healthcare Partners sold out of Vera Therapeutics (VERA) in Q1 2026, closing a stake of 100,564 shares — an estimated $5.09M sold.

Parkman Healthcare Partners first reported a position in VERA in Q2 2021 and held it in 7 quarters. The position peaked at $5.09M in Q4 2025. 229 funds tracked by Wall St. Rank hold VERA as of Q1 2026.

  • Parkman Healthcare Partners reported no remaining Vera Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Parkman Healthcare Partners sold 100,564 Vera Therapeutics shares in Q1 2026, an estimated $5.09M.
  • Parkman Healthcare Partners first reported a position in Vera Therapeutics in Q2 2021 and held it in 7 quarters.
  • Parkman Healthcare Partners's Vera Therapeutics position peaked at $5.09M in Q4 2025.
  • 229 funds tracked by Wall St. Rank held Vera Therapeutics as of Q1 2026.

Based on Parkman Healthcare Partners's 13F filing for Q1 2026, filed 15 May 2026.